|
|
||||||||
Articles |
Department of Nephrology and Medical Intensive Care, Universitatsklinikum Charite, Campus Virchow-Klinikum, Medizinische Fakultat der Humboldt-Universitat zu Berlin, Germany.
OBJECTIVES: High concentrations of glucose and/or formation of glucose degradation products (GDPs) during heat sterilization of peritoneal dialysis fluids (PDFs) are believed to be key factors in the limited biocompatibility of PDFs. We have previously shown that several identified GDPs can specifically impair human peritoneal mesothelial cell (HPMC) function. In the present study we aimed at differentiating the respective roles of glucose and GDPs in the toxicity of PDF to mesothelial cells. METHODS: HPMCs were acutely pre-exposed to or incubated chronically in the presence of pH-neutral PDF sterilized by either heat (H-PDF) or filtration (F-PDF). In addition, HPMCs were treated with commercially available H-PDF manufactured either conventionally, that is, in single-chamber containers, or using novel dual-chamber bags that help to substantially decrease GDP formation. Functional assessment of HPMCs included viability, release of interleukin (IL)-6, and proliferation. RESULTS: Viability and release of IL-6 from HPMCs pretreated with H-PDF (pH 7.3) for 1 to 4 hours were significantly reduced compared to cells exposed to corresponding F-PDF. Incubation in medium mixed (1:1) with H-PDF considerably impaired growth of HPMCs, and over a period of 10 days gradually decreased both the viability of HPMCs and their ability to generate IL-6. These effects were either absent from or significantly less in HPMCs exposed to F-PDF. Similar differences were observed when commercial GDP-containing H-PDFs were compared with newly designed H-PDFs free of GDPs. CONCLUSIONS: Impaired viability and function of HPMCs exposed to glucose-containing pH-neutral PDF is related predominantly to the presence of GDP and, to a significantly lesser extent, to the presence of glucose per se. Prevention of GDP formation during autoclaving markedly improves the biocompatibility of H-PDF with HPMCs.
This article has been cited by other articles:
![]() |
M. F. Flessner, K. Credit, K. Henderson, H. M. Vanpelt, R. Potter, Z. He, J. Henegar, and B. Robert Peritoneal Changes after Exposure to Sterile Solutions by Catheter J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2294 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Schwenger, C. Morath, A. Salava, K. Amann, Y. Seregin, R. Deppisch, E. Ritz, A. Bierhaus, P. P. Nawroth, and M. Zeier Damage to the Peritoneal Membrane by Glucose Degradation Products Is Mediated by the Receptor for Advanced Glycation End-Products J. Am. Soc. Nephrol., January 1, 2006; 17(1): 199 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Flessner The transport barrier in intraperitoneal therapy Am J Physiol Renal Physiol, March 1, 2005; 288(3): F433 - F442. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Boulanger, M.-P. Wautier, P. Gane, C. Mariette, O. Devuyst, and J.-L. Wautier The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2208 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Witowski, K. Korybalska, K. Ksiazek, J. Wisniewska-Elnur, A. Jorres, C. Lage, T. P. Schaub, J. Passlick-Deetjen, A. Breborowicz, A. Grzegorzewska, et al. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells Nephrol. Dial. Transplant., April 1, 2004; 19(4): 917 - 924. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |